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Outcome of Severe Obsessive–compulsive Disorder
With Schizotypal Features: A Pilot Study
Lung-Cheng Huang,1,2† Tzung-Jeng Hwang,3,4†* Guan-Hua Huang,5 Hai-Gwo Hwu3,4
Background/Purpose: Long-term outcome of patients with severe obsessive–compulsive disorder (OCD)
and schizotypal features has been rarely studied. We investigated this issue in this retrospective pilot study.
Methods: Twenty-two patients with severe OCD and schizotypal features were identified by chart review.
Another 22 OCD patients without schizotypal features (OCD-NS) served as the comparison group. Those
with schizotypal features must not fulfill a diagnosis of schizophrenia or schizotypal disorder. After an av-
erage follow-up of 6.6 years, each patient received a re-diagnosis clinical interview. Relevant demographic
and clinical data were collected. Patients with schizotypal features were classified into two groups after re-
diagnosis: those with schizophrenia or schizotypal disorder (OCD-SS group, n = 9) and those with only
schizotypal traits (OCD-ST group, n = 13) that did not fulfill a well-formed schizophrenia-spectrum disorder.
Demographic data, family history, clinical symptoms, and OCD course were compared among the three
patient groups.
Results: Compared with the OCD-NS group, the OCD-SS group was significantly less educated, less likely
to be married or female, and had earlier onset of illness and poorer OCD course (p < 0.05). There was no
significant difference in any demographic and clinical variables between the OCD-SS and OCD-ST groups
except that the OCD-ST group had a significantly better OCD course (p < 0.01).
Conclusion: The findings suggest that a substantial proportion of the patients with severe OCD and
schizotypal features evolve into schizophrenia spectrum disorder and are associated with a poor long-term
outcome, whereas the OCD-NS group might stay with limited manifestations of schizotypal features and
have a better outcome.
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It is now recognized that obsessive–compulsive
disorder (OCD) affects approximately 2–3% of the
world’s population, and it is a chronic and often
disabling mental disorder.1,2 OCD has heteroge-
neous manifestations and can be associated with
schizotypal features. The estimated prevalence of
schizotypal features in patients with OCD ranges
from 0 to 50%, depending on various definitions
and measurement tools, as reviewed by Poyurovsky
et al.3 For example, in a large series of 475 OCD
patients, 4% had concomitant schizophrenia, and
3% had concomitant schizotypal personality dis-
order.4 Another study found that 50% of 119 OCD
patients had positive schizotypal symptoms.5
Previous studies have shown that schizotypal
features in OCD are associated with early onset
of illness, comorbid diagnoses, special types of
obsessive–compulsive symptoms (OCSs),5 in-
creased impairment of cognitive function,6 and
reduced gray matter volume.7 Several reports have
demonstrated that the presence of schizotypal
personality disorder (SPD) predicts a poorer re-
sponse to drug or behavior therapy.8–11 Further-
more, SPD has been found to be more common
in OCD patients whose insight remains poor even
after treatment.12
In the era of the International Classification of
Diseases 9th edition (ICD-9), some OCD patients
with obvious schizotypal features, such as con-
comitant eccentric behavior, anomalies of affect, or
inconsequent personality, were diagnosed with
latent schizophrenia.13 In severe cases of OCD, 
insight can become tenuous as obsessions progress
to overvalued ideas or delusions, which has
prompted the special diagnostic specifier in the
Diagnostic and Statistical Manual of Mental
Disorders 4th edition of OCD with poor insight.14
In daily practice, there is a subgroup of OCD pa-
tients who have severe OCSs as well as concomitant
schizotypal features. Little is known about the
long-term course and outcome of these patients.
In fact, there has been sparse research into the
long-term outcome of OCD with schizotypal fea-
tures, as demonstrated by the limited number of
reviews of OCD outcome.15 Given the paucity of
literature in this area, we conducted a pilot study
to investigate the long-term outcome of severe
OCD with schizotypal features. We aimed to trace
the course and outcome of severe OCD with
schizotypal features, and identify relevant clini-
cal correlates associated with different outcome.
Methods
Subjects and design
To study severe OCD with schizotypal features,
we retrospectively reviewed the admission records
(1986–1996) of the National Taiwan University
Hospital and collected data on patients with severe
OCD with schizotypal features. We only selected
patients who fulfilled three inclusion criteria: 
(1) severe OCSs as defined by a Yale–Brown
Obsessive–Compulsive Scale (Y-BOCS)16,17 score
of ≥ 24, which usually necessitates hospital-
ization; (2) 1–3 of the nine symptom criteria 
of the ICD-10 schizotypal disorder18 for at least 
3 months before receiving any antipsychotic treat-
ment, yet not severe enough to fulfill a diagnosis
of schizophrenia or schizotypal disorder; and (3)
an OCD course of at least 6 months, that is, not
an acute transient episode. The retrospective rat-
ing of the Y-BOCS was done by two psychiatrists
(T.J. Hwang and Y.J. Lee) simultaneously to reach
a consensus. If there was any doubt, the patient
was excluded. Exclusion criteria included the
presence of mental retardation, schizophrenia,
schizoaffective disorder, persistent delusional dis-
order, a history of head injury, or active diagnosis
of substance abuse or dependence. A total of 
27 patients were found. As a result of severe clin-
ical symptoms and functional impairment, all the
patients had undergone vigorous pharmacother-
apy (including antiobsessive and antipsychotic
drugs for at least 3 months), and supportive psy-
chotherapy. Some had also received cognitive-
behavioral therapy or electroconvulsive therapy
for refractory symptoms. For comparison, we 
selected another 22 OCD patients during the same
period as the control group. The inclusion criteria
were: (1) a confirmed diagnosis of OCD; and (2)
no significant concomitant schizotypal features.
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These patients also received retrospective rating
of the Y-BOCS.
The patients were contacted to participate in
follow-up interviews at an average of 6.6 years after
they fulfilled the enrollment criteria. Of the 27 pa-
tients with severe OCD and schizotypal features,
three were not contactable, and two refused to
participate in the study. The remaining 22 pa-
tients with severe OCD and schizotypal features
and the other 22 pure OCD patients agreed to join
the study and signed an informed consent state-
ment after the detailed procedure was explained to
them. To confirm the current clinical status and
long-term course of our sample, all 44 subjects
received a re-diagnosis clinical interview, based
on ICD-10 criteria, to determine whether schizo-
phrenia or schizotypal disorder occurred during
the follow-up period. To focus on the evolution of
schizotypal features, we did not assess other con-
comitant depressive or anxiety symptoms that
usually fluctuated during the course. The clinical
interview was done by a psychiatrist (T.J. Hwang)
to ensure proper detection of nuances of behavior
and history that were necessary for the correct di-
agnosis. The results were discussed with another
senior psychiatrist (Y.J. Lee) to reach a final deci-
sion based on their consensus. For a diagnosis of
ICD-10 schizotypal disorder, at least four of the
nine criteria must have persisted for 2 years. Those
who fulfilled ≤ 3 criteria were classified as only
having schizotypal traits. The interview also re-
corded demographics, family history, OCSs, and
other clinical data. Measurement of socioeco-
nomic status (SES) was based on the Hollingshead
Index.19 The Hollingshead Index ranges from 
1 (families of wealth, graduate education, top-rank
social prestige) to 5 (unskilled and semi-skilled
workers, elementary education). Subjects who had
a Hollingshead Index score of 4 or 5 were classi-
fied as low SES.
At the end of follow-up, out of 22 patients with
severe OCD and schizotypal features, four met
the ICD-10 criteria for schizophrenia, five met the
ICD-10 criteria for schizotypal disorder, and 13 met
the criteria for schizotypal traits after a re-diagnosis
procedure. Thus, the first nine patients formed
the schizophrenia spectrum disorder group (OCD-
SS), and the latter 13 patients with schizotypal
traits formed the OCD-ST group. Of the 22 patients
with an initial diagnosis of pure OCD without
schizotypal features, none developed significant
schizotypal features during follow-up; therefore,
they formed the non-schizotypal group (OCD-NS).
Classification of symptoms and outcome
The OCSs were classified into six subgroups:
contamination/washing/avoidance; doubt/check-
ing; obsessive thought without compulsion;
symmetry/precision with compulsive slowness;
mixed (at least two of the above-mentioned OCS
subgroups); and other (such as peculiar sexual
obsessions and rituals). Degree of insight was as-
sessed using the insight question of the Y-BOCS.
The insight question of the Y-BOCS was rated on a
0–4-point scale that represented “excellent insight”
(0) to “lacks insight, delusional” (4). Subjects
who had a score raging of 3 or 4 were considered to
have “poor insight”. The course of OCD was based
on previous research4 and defined as follows: (1)
deteriorative with no remission: gradual functional
deterioration with or without OCS; (2) continuous
with no remission: maintaining similar level of
OCS severity and function, without improvement
or deterioration; (3) waxing and waning course:
periods of partial remission of OCSs and function
for > 6 months; or (4) episodic course: periods of
complete remission of OCSs and function 
> 6 months. Subjects who had a waxing and wan-
ing course or episodic course were considered to
have a “fair course”.
Data analysis
We compared the demographic data, psycho-
pathology (insight and OCSs), and outcome vari-
ables (OCD course) among the three groups of
patients: OCD-NS, OCD-SS, and OCD-ST. One-
way analysis of variance was conducted on con-
tinuous variables, and the χ2 (or Fisher’s exact) test
was performed on categorical variables. When
there was a significant difference (p < 0.05) of a
continuous variable, the Tukey honestly significant
difference or Games–Howell test was adopted for
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post hoc multiple pairwise comparisons depend-
ing on test of homogeneity of variances. Rates
and proportion with a two-tailed 95% confidence
interval were calculated for the variables of inter-
est. All data were analyzed using SPSS version 10.0
(SPSS Inc., Chicago, IL, USA).
Results
Nine (41%) of the 22 patients with severe OCD
and schizotypal features developed schizotypal
disorder or schizophrenia during the follow-up
period. The mean time to conversion was 3.1 years.
Table 1 compares demographic profiles, clinical
correlates and family history among the three
groups. Compared with the OCD-NS group, the
OCD-SS group was significantly younger, less edu-
cated, less likely to be married or female, and had
earlier onset of illness (p < 0.05). Compared with
the OCD-NS group, the OCD-ST group was also
significantly younger and less likely to be married
(p < 0.05). By contrast, there was no significant
difference on any demographic variable between
the OCD-SS and OCD-ST groups. The baseline 
Y-BOCS score of the OCD-SS and OCD-ST groups
was significantly higher than that of the OCD-NS
group, but there were no significant differences
in the follow-up Y-BOCS scores among the three
groups. No significant differences among the
three groups were found for duration of illness,
years of follow-up, SES, family history of OCD or
psychotic disorders.
There was no significant difference in OCSs
among the three OCD groups (Table 2). The OCD-
SS and OCD-ST groups tended to have more “other
symptoms” than the OCD-NS group, and there was
a borderline significance among the three groups
(p = 0.09). Those with other symptoms included
two patients in the OCD-NS group: impulsive
staring/compulsive avoidance of male genital or-
gans, ritualized bathing and eating behaviors; three
in the OCD-SS group: pervasive contamination
obsessions with undoing behaviors and magical
thinking, counting compulsions, pervasive undo-
ing thoughts and behaviors with magic thinking;
and five in the OCD-ST group: pervasive patho-
logical doubting, pervasive religious obsessions
Table 1. Comparison of demographic data, clinical correlates, and family history in three different
obsessive–compulsive disorder groupsa
OCD-NS OCD-SS OCD-ST 
c2 or F
(n = 22) (n = 9) (n = 13)
Demographic data and clinical correlates
Age (yr) 35.5 ± 13.2 23.5 ± 4.0b 25.0 ± 5.9b 6.66c
Age of onset (yr) 24.0 ± 12.8 15.1 ± 2.8 16.3 ± 6.3 3.79b
Duration of illness (yr) 11.5 ± 9.1 8.5 ± 3.6 8.7 ± 5.3 0.85
Years of follow-up (yr) 7.4 ± 6.5 6.3 ± 2.3 5.7 ± 2.9 0.51
Male sex 9 (40.9) 8 (88.9)d 8 (61.5) 6.16e
Married 10 (45.5) 0 (0)d 1 (7.7)d 9.99c
College education 12 (54.5) 0 (0)b 3 (23.1) 9.45c
Low SES 6 (27.3) 6 (66.7) 6 (46.2) 4.31
Baseline Y-BOCS 17.6 (5.7) 26.9 (5.4)b 26.3 (4.7)b 15.3c
Follow-up Y-BOCS 8.5 (4.9) 13.6 (10.4) 9.7 (6.5) 1.8
Family history
OCD 3 (13.6) 0 (0) 2 (15.4) 1.48
Psychotic disorders 3 (13.6) 3 (33.3) 3 (23.1) 1.60
aData presented as mean ± standard deviation or n (%); bp < 0.01: versus OCD-NS; cp < 0.01: (two-tailed) for comparison among the
three groups; dp < 0.05: versus OCD-NS; ep < 0.05. OCD=obsessive-compulsive disorder; OCD-NS=OCD with no schizotypal features;
OCD-SS=OCD with schizophrenia-spectrum disorders (schizophrenia or schizotypal disorder); OCD-ST = OCD with schizotypal traits;
SES = socioeconomic status; Y-BOCS = Yale–Brown Obsessive–Compulsive Scale.
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with undoing behaviors, dysmorphophobia,
dysmorphophobia + needs to ask/touch, peculiar
sexual obsessions+AIDS phobia+pervasive patho-
logical doubting. Compared with the OCD-NS
group, the OCD-ST group was significantly less
likely to have better insight. With respect to the
outcome measures, the OCD course most com-
monly found was waxing and waning in the
OCD-NS and the OCD-ST group, and deteriorative
without remission in the OCD-SS group (Table 2).
Compared with the other two groups, the OCD-
SS group was significantly more likely to have a
deteriorative course of illness (p < 0.01). By con-
trast, there was no significant difference between
the OCD-ST and OCD-NS groups for the distribu-
tion of OCD course. When episodic and waxing
and waning courses were combined into a fair
course, the OCD-SS group was significantly less
likely to have a fair course (OCD-SS, 0%; OCD-NS,
81.8%; OCD-ST, 84.6%; χ2 = 21.9, p < 0.001).
Discussion
Our pilot study had two main findings. First, 
a substantial proportion (41%) of the patients
with severe OCD and schizotypal features pro-
gressed to full-blown schizophrenia or schizotypal
disorder. Second, although the OCD-ST group was
similar to the OCD-SS group in terms of age, age
of onset, marital status, and baseline Y-BOCS score,
the long-term outcome might not have been as
poor as that of the OCD-SS group.
The presence of schizotypal features is a risk
factor for development of schizophrenia or schizo-
typal disorder, as demonstrated by the early psy-
chosis projects.20,21 Those with some schizotypal
or quasi-psychotic symptoms were at greater risk of
developing into schizophrenia or schizotypal
disorder when compared with those without.
Compared with OCD patients without schizotypal
features, OCD patients with schizotypal features
have been shown to have more severe reduction
of gray mater volume7 and frontal cognitive dys-
function.6 These findings are in line with the re-
sults of studies in at-risk subjects who had frontal
cognitive dysfunction and gray matter reduction
during development towards schizophrenia.22 In
addition, severe OCSs might be associated with
poor outcome and presence of SPD.10,23 Taken
together, these factors can explain why a higher
proportion of our patients with severe OCD and
Table 2. Comparison of symptoms and course in different obsessive–compulsive disorder groupsa
OCD-NS (n = 22) OCD-SS (n = 9) OCD-ST (n = 13) c2 or F
OCS subgroup 9.48
Contamination/washing 5 (22.7) 1 (11.1) 1 (7.7)
Doubt/checking 2 (9.1) 0 (0) 3 (23.1)
Obsessive thought 3 (13.6) 2 (22.2) 2 (15.4)
Symmetry/precision 1 (4.5) 1 (11.1) 0 (0)
Mixed 9 (40.9) 2 (22.2) 2 (15.4)
Other 2 (9.1) 3 (33.3) 5 (38.5)
Insight
Poor insight 3 (13.6) 4 (44.4) 9 (69.2)c 11.23b
OCD course 23.47b
Deteriorative 1 (4.5) 5 (55.6)d 2 (15.4)
Continuous 3 (13.6) 4 (44.4) 0 (0)
Waxing and waning 12 (54.5) 0 (0) 7 (53.8)
Episodic 6 (27.3) 0 (0) 4 (30.8)
aData presented as n (%); bp < 0.01: (two-tailed) for comparison among the 3 groups; cp < 0.01: OCD-ST vs. OCD-NS; dp < 0.01: 
OCD-SS vs. OCD-NS; OCD-SS vs. OCD-ST. OCD = obsessive–compulsive disorder; OCD-NS = OCD with no schizotypal features; 
OCD-SS = OCD with schizophrenia-spectrum disorders (schizophrenia or schizotypal disorder); OCD-ST = OCD with schizotypal traits;
OCS = obsessive–compulsive symptom.
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schizotypal features evolved into schizophrenia
spectrum disorder.
Previous family and twin studies have shown
that OCD is a familial disorder,24 and that OCD
and schizophrenia can be inherited together but
with different severity of schizotypal symptoms
and outcome.25 Our study found that the OCD-ST
and OCD-SS groups were similar in age of onset,
marital status, and baseline Y-BOCS score but dif-
ferent in long-term outcome. One explanation
for this is related to the concept of “schizotaxia”,26
which suggests that the genetic liability for schizo-
phrenia could be manifested, even without the
full manifestations of schizophrenia. This liability
is characterized by neurological, neurobiological,
psychiatric, neuropsychological, and psychosocial
impairments, in non-psychotic first-degree relatives
of people with schizophrenia.27 By modification
of the concept of schizotaxia, Tsuang and col-
leagues have proposed that the predisposition to
develop schizophrenia in non-prodromal, non-
psychotic adult relatives of patients with schizo-
phrenia might be expressed as a meaningful,
diagnosable, clinical syndrome or set of traits.28
Moreover, there is evidence that the schizotaxic
subjects might have a positive response following
treatment with low-dose antipsychotics.28 Given
that our non-schizophrenic OCD-ST group exhib-
ited substantial rates of a family history of psychotic
disorders (23.1%), poor social–occupational
functioning, poor insight, more unusual OCSs,
and a positive response to treatment, this group
of individuals might represent schizotaxic char-
acteristics to some extent. This could have ac-
counted for their better outcome after treatment.
It would be interesting to establish baseline fac-
tors among these OCD patients with schizotypal
features that could predict future development
into the OCD-SS or OCD-ST group. Unfortu-
nately, our study could not find any significant
predictor since there was no significant difference
in the baseline demographic data and clinical cor-
relates between the two groups. Clearly, further
studies with a larger sample size and prospective
design will be needed to elucidate the real nature
of these patients.
Our results were in accordance with previous
findings that OCD patients with psychotic features
are more likely to be single and have a deteriorative
course,4 at least in the OCD-SS group. The symp-
toms used to define OCD are diverse and include a
range of obsessions and compulsions. Some au-
thors have described the increased rate of a certain
type of OCSs subgroup (e.g. counting compul-
sions) in OCD patients with psychotic features.5
Our data showed no significant difference in the
OCSs subgroup of the three OCD groups. The
OCD-SS and OCD-ST groups tended to have more
other symptoms than the OCD-NS group (p =
0.09). This could have been due to the coexistence
of OCD and schizotypal features in the former two
groups, which made the manifestation of OCSs
become more unusual.
A generalization of our results must be viewed
with caution, considering the retrospective and
observational nature of the analysis and the small
sample size. Given the limited number of OCD
patients with and without schizotypal features,
there was possible selection bias when enrolling
the study sample. The retrospective review of base-
line OCD severity and schizotypal features might
not be sufficiently accurate, although this could
be less problematic for the OCD-SS and OCD-ST
groups because > 90% of these patients were ad-
mitted with detailed records of their clinical mani-
festations. The outcome measure (OCD course)
was clinical rather than scale-based. The medica-
tions were not well-controlled due to the retro-
spective and observational study design, although
the patients with severe OCD and schizotypal
features always received vigorous treatment. It is
possible that some patients’ schizotypal features
were masked by antipsychotics, so they were classi-
fied in the OCD-ST rather than OCD-SS group.
Another limitation is that we did not assess other
comorbid disorders such as anxiety, depressive,
or personality disorders. The baseline Y-BOCS score
was not comparable between the OCD-NS and the
other two groups; therefore, it could have been a
confounder of outcome measurement. However,
past studies have already shown that OCD patients
with schizotypal features have poorer outcome
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than those without such features, even when both
groups have similar severity of OCSs.8,11,29 The
value of our study is to demonstrate the different
outcome between the OCD-SS and OCD-ST
groups. Clearly, further research needs to be un-
dertaken with a larger sample size, standardized
scales, and a prospective, systematic design to
clarify the subtyping and clinical outcome of se-
vere OCD with schizotypal features.
In summary, our study identifies the clinical
course and outcome of severe OCD with schizo-
typal features. Our results suggest that a substan-
tial proportion of these patients evolve into
schizophrenia spectrum disorder and are associ-
ated with poor long-term outcome, whereas
other patients might stay with limited manifesta-
tions of schizotypal features and have a better
outcome following vigorous treatment.
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